Digital Health in India: Catalyst for Equity or a Regulatory Time Bomb?

An analysis of India’s digital health transformation and the urgent need for a unified and adaptive regulatory framework

Law Firm - Cyril Amarchand Mangaldas
By: :  Biplab Lenin
By: :  Kartik Jain
Update: 2026-02-05 04:30 GMT


Digital Health in India: Catalyst for Equity or a Regulatory Time Bomb?

The need of the hour is a unified legal framework that recognizes digital health as a distinct and inalienable part of healthcare delivery.

The healthcare sector in India is undergoing a massive transformation, and ‘Digital Health’ delivery has taken centre stage in this conversation. Now, digital health is embedded in the very fabric of how healthcare is delivered, accessed and financed, and for a nation dealing with systemic shortages of doctors, infrastructure, and last mile access, the promise is real. However, the laws governing healthcare in India still lag behind. This growing divide isn’t just a policy inconvenience, but also poses serious risks vis-à-vis public health and trust. The big question is no longer if India should embrace digital health, but if the laws of India can effectively keep pace with this acceleration, and administer it in a responsible way.

Indian healthcare regulations traditionally, were product-focused, doctor-driven and centred on very well-known entities like medicines, medical equipment and medical workers, which are separated into neat little boxes that were made for the physical, analogue world. Digital health technologies don’t fit so neatly into these categories. Software isn’t like a pill, a calculation isn’t like a medical device and data flowing through a system isn’t something that can be tightly controlled.


As a result, we are facing extensive regulatory ambiguity. On one hand, regulators and those in the industry are constantly trying to fit brand-new realities into old definitions. Sometimes digital tools are over-regulated, made to seem like high-stakes medical products even when they don’t have much of an impact on patients. On the other hand, they sometimes go completely unscathed because no clear laws apply to them.

E-Pharmacies and the Cost of Legal Vacuum:

Few areas highlight regulatory inaction as clearly as online pharmacies. Despite their widespread use, e-pharmacies still operate in a grey zone of the law. Existing drug laws were created for physical pharmacies and provide little guidance on online ordering, digital prescriptions, interstate delivery, or platform accountability. This legal gap has real consequences. While patients benefit from convenience and access, especially in areas with few physical pharmacies, concerns about misuse of prescription drugs, lack of pharmacist oversight, and uncontrolled interstate supply remain. Courts have tried to fill the void with temporary orders, but judicial action cannot replace effective legislation. The ongoing lack of clear statutory rules creates uncertainty for businesses and weakens public health protections. A sector that directly impacts access to medicines should not be governed by confusion and inconsistent enforcement.

Health Data, Trust, and the Limits of Consent:

Digital health relies heavily on data. Electronic health records, predictive analytics, personalized treatment, and population-level insights depend on collecting and sharing sensitive health data. However, the law has not yet addressed the ethical and legal challenges of health data governance. While general data protection principles are important, they are not enough for healthcare. Health data is particularly sensitive and can lead to discrimination, stigma, and long-term harm if mishandled. Consent in healthcare is often influenced by power imbalances and limited choices and without explicit safeguards, patients are forced to trust systems that provide little legal protection when problems arise. Trust requires enforceable rights, clear accountability, and meaningful limits on how health data is collected, shared, and monetized.

Telemedicine Beyond Crisis Management:

Telemedicine was formally recognized only during the Covid pandemic, when in-person consultations became difficult or unsafe. The resulting guidelines provided necessary clarity but also exposed the system’s hesitance. Telemedicine is still viewed as an exception rather than a fundamental part of healthcare. Current legal frameworks limit who can offer teleconsultations, what can be prescribed, and how digital interactions are recorded. While safeguards are necessary, excessive caution restricts telemedicine’s ability to fill significant gaps in healthcare access. For remote and underserved populations, digital consultations are not just a convenience; they are often the only practical option. For telemedicine to grow, the law must shift from crisis management to strategic integration.

The Case for a Coherent Digital Health Framework:

India’s digital health regulation is currently scattered across various laws, rules, guidelines, and draft policies. This fragmented approach brings uncertainty for innovators, investors, and uneven protection for patients. The need of the hour is a unified legal framework that recognizes digital health as a distinct and inalienable part of healthcare delivery. Such a framework should be based on risk-based regulation, clear definitions, and reasonable compliance requirements and cover software-based tools, online medicine supply, telemedicine, and health data governance in a unified way. Importantly, it must be flexible enough to evolve with technology, rather than locking innovation into outdated regulations. Reform in this sector should focus on smarter regulation that matches legal oversight with real-world risks and societal needs.

Conclusion:

Digital health gives India a unique opportunity to fill long-standing gaps in healthcare access, quality, and efficiency. However, innovation without legal clarity is fragile. The pace of technological developments and resultant business ecosystem is immense- companies are already venturing into omnichannel digital health delivery providing end to end services, from consultations to prescription to medicine delivery. If the law falls too far behind technology, it creates uncertainty and erodes trust, ultimately harming the very people innovation aims to help. The future of digital health in India relies not only on technological capability but also on legal thinking which keeps pace with technological developments. Like any other sector which is being transformed in the digital age, healthcare sector is also witnessing the same changes. The law must also reflect these developments and act as an enabler, balancing innovation with protection, growth with accountability, and efficiency with fairness. The challenge is urgent, but so is the opportunity. Whether digital health becomes a force for inclusion or a regulatory burden will depend on the choices lawmakers make now.

Disclaimer – The views expressed in this article are the personal views of the authors and are purely informative in nature.

Tags:    

By: - Biplab Lenin

Biplab Lenin is a Partner at Cyril Amarchand Mangaldas in its Pharma, Healthcare and Life Sciences practice, with 15 years of experience at the intersections of pharmaceuticals, healthcare, biotechnology, technology, and regulatory compliance, complemented by qualifications as an engineer and a registered patent agent. His expertise spans complex regulatory frameworks for pharmaceuticals, medical devices, clinical trials, nutraceuticals, and digital health, with extensive involvement in approvals, compliance, transactions, advisory mandates, and litigation across sectors. He regularly advises on corporate and commercial matters, including the drafting, review, and negotiation of a wide range of business agreements, and plays a significant role in intellectual property strategy, patent filing and prosecution, and biodiversity regulatory advisory. Biplab is recognised across leading global legal directories-India Business Law Journal (A List 2025; Vanguards 2026; Future Legal Leader 2024), Chambers & Partners Asia Pacific (“Up and Coming” 2025 & 2026), Legal Era (“Leading Lawyer Champion” 2024 & 2025), and Legal 500 Asia Pacific (“Next Generation Partner” 2024–2026; “Key Lawyer” 2023; nominee for “Life Sciences & Healthcare Lawyer of the Year” 2024). He is also the recipient of the Young Alumni Achiever Award 2025 from the Indian Institute of Technology, Kharagpur. He serves as visiting faculty at IIM Bodh Gaya and contributes regularly as a writer and speaker on digital health, regulatory developments, and the impact of technology on the healthcare sector.

By: - Kartik Jain

Kartik Jain is a Principal Associate in Cyril Amarchand Mangaldas’ Noida office. He is part of the general corporate team of the firm with a specialist focus in the areas of Pharmaceuticals, Healthcare and Life Sciences. A key area of focus for him is regulatory compliance advisory for clients in the pharma, medical devices, cosmetics nutraceuticals, healthcare services, hospitals, diagnostics, and R&D sector(s). Kartik also has extensive experience in advising clients on the nuances of regulatory issues and compliance requirements in ongoing mergers and acquisitions, demergers, and in strategic litigations pertaining to the pharmaceuticals and medical devices industry.

Similar News

Technology Meets Healthcare